Abstract:
In this chapter the assessment of quality of life in deaf people with a Cochlear Implant (CI) is discussed. First the background on this topic is elaborated on in the introduction. In the main text, the history of cochlear implantation and the system of a cochlear implant are depicted and shortly some indications to implant are given. The actual part in which the quality of life in CI patients is discussed, can be divided in several parts. At the outset, the overall quality of life in this particular population is mentioned together with some results. Afterwards, diverse disease specific instruments for the field of cochlear implantation are mentioned. Hereby we discuss the instrument itself, the statistics, the results and conclude with why to (or not to) use the instrument in the CI population. The instruments that are pointed out are: the Assessment of Mainstream Performance (AMP), the Glasgow (Children’s) Benefit Inventory (G-C-BI), the Nijmegen Cochlear Implant Questionnaire (NCIQ), the Parental Perspectives (PP) and the Screening Instrument For Targeting Educational Risk (SIFTER). Finally, some of the widely used generic instruments in CI recipients are given. The most important are the medical outcome study Short Form 36 (SF36), the Health Utility Index mark 3 (HUI3) and the Pediatrics Quality of Life (PedsQL). Recommendations are given in the end.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- AMP:
-
assessment of mainstream performance
- AMP-E:
-
assessment of mainstream performance elementary school
- AMP-K:
-
assessment of mainstream performance kindergarten
- CI:
-
cochlear implant
- dBHL:
-
deciBel hearing level
- FDA:
-
Food and Drug Administration
- GBI:
-
Glasgow benefit inventory
- GCBI:
-
Glasgow children’s benefit inventory
- HA:
-
hearing aid
- HRQOL:
-
health related quality of life
- HUI2:
-
health utility index mark 2
- HUI3:
-
health utility index mark 3
- MCS:
-
mental component summary score
- NCIQ:
-
Nijmegen cochlear implant questionnaire
- PCS:
-
physical component summary score (PCS)
- PedsQL:
-
pediatrics quality of life
- PP:
-
parental perspectives questionnaire
- QOL:
-
quality of life
- SD:
-
standard deviation
- SF36:
-
medical outcome study Short Form 36
- SIFTER:
-
Screening Identification For Targeting Educational Risk
References
Admiraal RJ. (1989). Ned Tijdschr Geneeskd. 133: 1913–1915.
Anderson KL. (1989). SIFTER Screening Identification for Targeting Educational Risk in Children Identified by Hearing Screening or who have Minimal Hearing Loss. The interstate printers and publishers, Danville, IL.
Anderson KL, Matkin ND. (1996). Preschool Screening Identification for Targeting Educational Risk. The educational audiology Association, Westminster, CO.
Archbold SM, Lutman ME, Gregory S, O'Neill C, Nikolopoulos TP. (2002). Deafness Educ Int. 4: 12–40.
Cheng AK, Rubin HR, Powe NR, Mellon NK, Francis HW, Niparko JK. (2000). JAMA. 284: 850–856.
Chmiel R, Sutton L, Jenkins H. (2000). Ann Otol Rhinol Laryngol Suppl. 185: 103–105.
Chute PM, Nevins ME, Parisier SC. (2004). Assessing Mainstream Performance in Children with Cochlear Implants Conference Proceeding. Geneva, Switzerland.
Cohen NL. (2004). Audiol Neurootol. 9: 197–202.
Cohen SM, Labadie RF, Dietrich MS, Haynes DS. (2004). Otolaryngol Head Neck Surg. 131: 413–422.
Cooper HR, Carpenter L, Aleksy W, Booth CL, Read TE, Graham JM, Fraser JG. (1989). J Laryngol Otol Suppl. 18: 22–38.
Damen GW, Oever van den-Goltstein M, Langereis MC, Chute PM, Mylanus EAM. (2006). Ann. Otol. Rhinol. Laryngol. 115: 542–552.
Damen GW, Beynon AJ, Krabbe PF, Mulder JJ, Mylanus EA. (2007a). Otolaryngol Head Neck Surg. 136: 597–604.
Damen GW, Hoffer MMR, Hoekstra CC, Mylanus EA. (2006b). Stem,- Spraak- en Taalpathologie (Dutch). 14: 143–160.
Damen GW, Krabbe PF, Archbold SM, Mylanus EA. (2007b). Int J Pediatr Otorhinolaryngol. 71: 425–433.
Damen GW, Langereis MC, Snik AF, Chute PM, Mylanus EA. (2007c). Otol Neurotol. 28: 463–472.
Damen GW, Pennings RJ, Snik AF, Mylanus EA. (2006a). Laryngoscope. 116: 723–728.
Dijourno A, Eyries C. (1957). Press Med. 35: 14–17.
Dujardin A, Sloovere de M, Raeve de L. (2003). Kinderen met een Cochleaire Inplant: meningen en ervaringen van ouders [Dutch]. Antwerp, Belgium, pp. 26–40.
Eiser C. (2007). Arch Dis Child. 92: 379–380.
Feeny D, Furlong W, Torrance GW, Goldsmith CH, Zhu Z, DePauw S, Denton M, Boyle M. (2002). Med Care. 40: 113–128.
Food and Drug Administration's, cochlear implant. (2006). Internet Communication Available at: www.fda.com
Furlong WJ, Feeny DH, Torrance GW, Barr RD. (2001). Ann Med. 33: 375–384.
Garabedian EN. (1992). Rev Infirm. 42: 44–46.
Grutters JP, Joore MA, Verschuure H, Dreschler WA, Anteunis LJ. (2007). Qual Life Res. 16: 1439–1449.
Hinderink JB, Krabbe PF, Van Den P. Broek (2000). Otolaryngol Head Neck Surg. 123: 756–765.
Hinderink JB, Mens LH, Brokx JP, Van Den P. Broek (1995). Laryngoscope. 105: 618–622.
Horsman J, Furlong W, Feeny D, Torrance G. (2003). Health Qual Life Outcomes. 1: 54.
House W, Berliner K. (1991). Cochlear implants: From idea to clinical practice. In: Cooper H (ed.) Cochlear Implants: A Practical Guide. Whurr Publishers, London.
Jansen YJ, Bal R, Bruijnzeels M, Foets M, Frenken R. (2006). BMC Health Serv Res. 6: 160.
Klop WM, Boermans PP, Ferrier MB, van den Hout WB, Stiggelbout AM, Frijns JH. (2008). Otol Neurotol. 29(5): 615–621.
Klop WM, Briaire JJ, Stiggelbout AM, Frijns JH. (2007). The Laryngoscope 117: 1982–1987.
Knutson JF, Johnson A, Murray KT. (2006). Br J Health Psychol. 11: 279–292.
Krabbe PF, Hinderink JB, Van Den P. Broek (2000). Int J Technol Assess Health Care. 16: 864–873.
Kubba H, Swan IR, Gatehouse S. (2004). Ann Otol Rhinol Laryngol. 113: 980–986.
Mo B, Lindbaek M, Harris S. (2005). Ear Hear. 26: 186–194.
Niparko JK, Blankenhorn R. (2003). Ment Retard Dev Disabil Res Rev. 9: 267–275.
Nunes T, Pretzlik U. (2003). An Independent Assessment and Evaluation of a Profile from Parents of Children with a Cochlear Implant. Oxford Brookes University, Oxford, UK.
O'Neill C, Lutman ME, Archbold SM, Gregory S, Nikolopoulos TP. (2004). Int J Pediatr Otorhinolaryngol. 68: 149–160.
Pennings RJ, Damen GW, Snik AF, Hoefsloot L, Cremers CW, Mylanus EA. (2006). Laryngoscope. 116: 717–722.
Robinson K, Gatehouse S, Browning GG. (1996). Ann Otol Rhinol Laryngol. 105: 415–422.
Varni JW, Burwinkle TM, Seid M, Skarr D. (2003). Ambul Pediatr. 3: 329–341.
Varni JW, Seid M, Kurtin PS. (2001). Med Care. 39: 800–812.
Varni JW, Seid M, Rode CA. (1999). Med Care. 37: 126–139.
Vermeire K, Brokx JP, Wuyts FL, Cochet E, Hofkens A, Van de Heyning PH. (2005). Otol Neurotol. 26: 188–195.
Vlahovic S, Sindija B. (2004). Int J Pediatr Otorhinolaryngol. 68: 1167–1174.
Ware JE Jr, Sherbourne CD. (1992). Med Care. 30: 473–483.
Wiley S, Jahnke M, Meinzen-Derr J, Choo D. (2005). Int J Pediatr Otorhinolaryngol. 69: 791–798.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media LLC
About this entry
Cite this entry
Damen, G.W.J.A., Mylanus, E.A.M., Snik, A.F.M. (2010). Cochlear Implantation and Quality of Life in Deafness. In: Preedy, V.R., Watson, R.R. (eds) Handbook of Disease Burdens and Quality of Life Measures. Springer, New York, NY. https://doi.org/10.1007/978-0-387-78665-0_226
Download citation
DOI: https://doi.org/10.1007/978-0-387-78665-0_226
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-78664-3
Online ISBN: 978-0-387-78665-0
eBook Packages: MedicineReference Module Medicine